These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 9467166

  • 1. [Paradoxical effect of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy].
    Dunkelmann S, Rudolph F, Prillwitz A, Groth P, Schümichen C.
    Nuklearmedizin; 1998 Jan; 37(1):23-9. PubMed ID: 9467166
    [Abstract] [Full Text] [Related]

  • 2. [Radioiodine therapy of autonomously functioning thyroid nodules and Graves' disease].
    Guhlmann CA, Rendl J, Börner W.
    Nuklearmedizin; 1995 Feb; 34(1):20-3. PubMed ID: 7724360
    [Abstract] [Full Text] [Related]

  • 3. Graves' ophthalmopathy and 131I therapy.
    Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Mazzi B, Rocchi R, Barbesino G, Pinchera A.
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC, Zanin DE, Zweers EJ.
    Ned Tijdschr Geneeskd; 2002 Sep 28; 146(39):1837-41. PubMed ID: 12382370
    [Abstract] [Full Text] [Related]

  • 5. [Experience with ambulatory radioiodine therapy of hyperthyroidism].
    Róka R, Séra T, Valkusz Z, Julesz J, Csernay L, Pávics L.
    Orv Hetil; 1999 Jun 06; 140(23):1291-5. PubMed ID: 10412264
    [Abstract] [Full Text] [Related]

  • 6. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L, De Palma D, Ceriani L, Vanoli P, Garancini S, Tordiglione M, Tarolo GL.
    Radiol Med; 2000 Dec 06; 100(6):480-3. PubMed ID: 11307510
    [Abstract] [Full Text] [Related]

  • 7. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R, Sripathy G.
    Natl Med J India; 2000 Dec 06; 13(5):246-51. PubMed ID: 11190053
    [Abstract] [Full Text] [Related]

  • 8. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S, Jaatinen P, Huhtala H, Luukkaala T, Oksala H, Salmi J.
    Clin Endocrinol (Oxf); 2004 Nov 06; 61(5):641-8. PubMed ID: 15521969
    [Abstract] [Full Text] [Related]

  • 9. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
    Traino AC, Di Martino F, Grosso M, Monzani F, Dardano A, Caraccio N, Mariani G, Lazzeri M.
    Phys Med Biol; 2005 May 07; 50(9):2181-91. PubMed ID: 15843745
    [Abstract] [Full Text] [Related]

  • 10. [Radioiodine therapy of recurrent hyperthyroidism in patients previously treated for diffuse toxic goiter with subtotal surgery].
    Vestergaard H, Laurberg P.
    Ugeskr Laeger; 1993 Aug 02; 155(31):2403-5. PubMed ID: 8346592
    [Abstract] [Full Text] [Related]

  • 11. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
    Alfadda A, Malabu UH, El-Desouki MI, Al-Rubeaan KA, Al-Ruhaily AD, Fouda MA, Al-Maatouq MA, Sulimani RA.
    Saudi Med J; 2007 Feb 02; 28(2):225-30. PubMed ID: 17268701
    [Abstract] [Full Text] [Related]

  • 12. [Graves' disease nd toxic nodular goiter--radioiodine therapy].
    Schicha H, Dietlein M.
    Nuklearmedizin; 2002 Apr 02; 41(2):63-70. PubMed ID: 11989300
    [Abstract] [Full Text] [Related]

  • 13. Thyroid cancer prevalence after radioiodine treatment of hyperthyroidism.
    Angusti T, Codegone A, Pellerito R, Favero A.
    J Nucl Med; 2000 Jun 02; 41(6):1006-9. PubMed ID: 10855625
    [Abstract] [Full Text] [Related]

  • 14. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism.
    Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A.
    N Engl J Med; 1989 Nov 16; 321(20):1349-52. PubMed ID: 2811943
    [Abstract] [Full Text] [Related]

  • 15. [Effect of iodine application during radioiodine therapy in patients with impending therapy failure].
    Urbannek V, Schmidt M, Moka D, Hillger HW, Voth E, Wellner U, Schicha H.
    Nuklearmedizin; 2000 Nov 16; 39(4):108-12. PubMed ID: 10919161
    [Abstract] [Full Text] [Related]

  • 16. [Stunning in radioiodine therapy of benign thyroid disease. Quantification and therapeutic relevance].
    Krohn T, Meyer PT, Ocklenburg C, Knollmann D, Nowak B, Schaefer WM.
    Nuklearmedizin; 2008 Nov 16; 47(6):248-54. PubMed ID: 19057798
    [Abstract] [Full Text] [Related]

  • 17. [Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents].
    Urbannek V, Voth E, Moka D, Schicha H.
    Nuklearmedizin; 2001 Aug 16; 40(4):111-5. PubMed ID: 11556200
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Radioiodine therapy and thyrostatic drugs and iodine.
    Moka D, Dietlein M, Schicha H.
    Eur J Nucl Med Mol Imaging; 2002 Aug 16; 29 Suppl 2():S486-91. PubMed ID: 12192550
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.